1. Home
  2. RKDA vs APVO Comparison

RKDA vs APVO Comparison

Compare RKDA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$3.11

Market Cap

5.8M

Sector

Industrials

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

21.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
APVO
Founded
2002
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
21.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RKDA
APVO
Price
$3.11
$0.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.8K
1.1M
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,173,000.00
N/A
Revenue This Year
$21.31
N/A
Revenue Next Year
$28.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.31
N/A
52 Week Low
$2.53
$0.91
52 Week High
$6.71
$109.80

Technical Indicators

Market Signals
Indicator
RKDA
APVO
Relative Strength Index (RSI) 30.11 31.90
Support Level $3.50 $1.00
Resistance Level $3.71 $1.11
Average True Range (ATR) 0.20 0.09
MACD -0.06 -0.01
Stochastic Oscillator 4.60 4.19

Price Performance

Historical Comparison
RKDA
APVO

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: